Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

AACR Annual Meeting 2013

6 - 10 Apr 2013
Walter E. Washington Convention Center, Washington DC, United States of America
Prevention of squamous cell carcinoma
Dr Kenneth Tsai - MD Anderson Cancer Center, Houston, USA
Prevention of squamous cell carcinoma ( Dr Kenneth Tsai - MD Anderson Cancer Center, Houston, USA )
23 Apr 2013
Myc inhibition in pre-clinical mouse models
Dr Laura Soucek - Vall d'Hebron Institute of Oncology
Myc inhibition in pre-clinical mouse models ( Dr Laura Soucek - Vall d'Hebron Institute of Oncology )
22 Apr 2013
Use of tobacco during cancer treatment
Dr Samantha Sobus – Roswell Park Cancer Institute, Buffalo, NY
Use of tobacco during cancer treatment ( Dr Samantha Sobus – Roswell Park Cancer Institute, Buffalo, NY )
22 Apr 2013
Immunotherapy in melanoma and other cancers
Dr Suzanne Topalian – Johns Hopkins, Baltimore, USA
Immunotherapy in melanoma and other cancers ( Dr Suzanne Topalian – Johns Hopkins, Baltimore, USA )
19 Apr 2013
Next generation gene sequencing
Dr John Mendelsohn – MD Anderson Cancer Center, Houston, TX, USA
Next generation gene sequencing ( Dr John Mendelsohn – MD Anderson Cancer Center, Houston, TX, USA )
19 Apr 2013
Genomic signatures and predictive biomarkers in breast cancer
Dr Charles Swanton - Cancer Research UK, London, UK
Genomic signatures and predictive biomarkers in breast cancer ( Dr Charles Swanton - Cancer Research UK, London, UK )
19 Apr 2013
Next generation PI3 kinase inhibition
Dr Maurizio Scaltriti – Massachusetts General Hospital, Boston, MA, US
Next generation PI3 kinase inhibition ( Dr Maurizio Scaltriti – Massachusetts General Hospital, Boston, MA, US )
19 Apr 2013
The aims of the WIN Consortium
Dr John Mendelsohn – MD Anderson Cancer Center, Houston, TX, USA
The aims of the WIN Consortium ( Dr John Mendelsohn – MD Anderson Cancer Center, Houston, TX, USA )
19 Apr 2013
Targeting tumour suppressor genes
Dr Douglas Lowy - National Cancer Institute, Bethesda, USA
Targeting tumour suppressor genes ( Dr Douglas Lowy - National Cancer Institute, Bethesda, USA )
19 Apr 2013
Closing the cancer divide: Implementing the diagonal approach
Dr Felicia Knaul - Harvard Medical School, Boston, USA
Closing the cancer divide: Implementing the diagonal approach ( Dr Felicia Knaul - Harvard Medical School, Boston, USA )
19 Apr 2013
Genome-wide methylation patterns suggest differences in breast cancer biology in...
Dr Christine Ambrosone - The Roswell Park Cancer Institute, Buffalo, USA
Genome-wide methylation patterns suggest differences in breast cancer biology in American women of African and European ancestry ( Dr Christine Ambrosone - The Roswell Park Cancer Institute, Buffalo, USA )
19 Apr 2013
Racial disparities in cancer outcomes
Dr Camille Ragin - Fox Chase Cancer Center, Philadelphia, USA
Racial disparities in cancer outcomes ( Dr Camille Ragin - Fox Chase Cancer Center, Philadelphia, USA )
19 Apr 2013
Vitamin D and cancer prevention
Dr Anna Woloszynska-Read
Vitamin D and cancer prevention ( Dr Anna Woloszynska-Read )
17 Apr 2013
Intermittent treatment with vemurafenib may prevent lethal drug resistance in me...
Dr Darrin Stuart - Novartis Institutes for Biomedical Research, Emeryville, CA, ...
Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma ( Dr Darrin Stuart - Novartis Institutes for Biomedical Research, Emeryville, CA, USA )
8 Apr 2013
Potential novel inhibitor to overcome drug resistance induced by RAF, MEK Inhibi...
Dr Ahmed Samatar - Merck Research Laboratories, Boston, USA
Potential novel inhibitor to overcome drug resistance induced by RAF, MEK Inhibitors ( Dr Ahmed Samatar - Merck Research Laboratories, Boston, USA )
8 Apr 2013
Sapacitabine and seliciclib, antitumour activity in patients with incurable BRCA...
Dr Geoffrey Shapiro - Dana-Farber Cancer Institute, Boston, USA
Sapacitabine and seliciclib, antitumour activity in patients with incurable BRCA-deficient cancers ( Dr Geoffrey Shapiro - Dana-Farber Cancer Institute, Boston, USA )
8 Apr 2013
AKT inhibitor AZD5363 in patients with advanced solid tumours
Dr Udai Banerji - Institute of Cancer Research, Sutton, United Kingdom
AKT inhibitor AZD5363 in patients with advanced solid tumours ( Dr Udai Banerji - Institute of Cancer Research, Sutton, United Kingdom )
8 Apr 2013